Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
How to Anticipate and Outmaneuver Your Rivals: A Case Study of Achieving Advantage in Pharmaceuticals
1. How to Anticipate and
Outmaneuver Your Rivals: A
Case Study of Achieving
Advantage in Pharmaceuticals
A Complimentary Webinar from Aurora WDC
12:00 Noon Eastern /// Wednesday 22 January 2014
~ featuring ~
Cliff Kalb
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Dr. Craig Fleisher
Powered by
2. Cliff Kalb
Cliff Kalb is the President and Owner at C. Kalb and Associates, LLC.
and has four decades of experience in the pharmaceutical industry,
both as a consumer and producer of intelligence. Cliff was
formerly Senior Vice President with Wood Mackenzie’s Life
Sciences Consultancy, and served as the Head of Strategic Business
Analysis at Merck & Co, Inc., their global intelligence function. Mr.
Kalb is Past President of both SCIP and PBIRG (Pharmaceutical
Business Intelligence and Research Group) and earned their
Lifetime Achievement Award. A SCIP Meritorious and Fellow
award winner, he has been named as one of the top 100 most
inspiring people in the pharmaceutical industry by Pharmavoice,
and serves on the Advisory Board of Pharmaceutical Executive
Magazine.
Email: CKalb55205@aol.com
The Intelligence Collaborative is the online learning and networking
community powered by Aurora WDC, our clients, partners and other friends
and dedicated to exploring how to apply intelligence methods to solve realworld business problems.
Apply for a free 30-day trial membership at http://IntelCollab.com or learn
more about Aurora at http://AuroraWDC.com – see you next time!
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
3. Questions, Commentary & Content
α
α
α
α
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Use the Questions pane on your GoToWebinar
control panel and all questions will be answered in
the second half of the hour.
You are welcome to tweet any comments on
Twitter where we are monitoring the hashtag
#IntelCollab or eavesdrop via
http://tweetchat.com/room/IntelCollab
Slides will be available after the webinar for
embedding and sharing via
http://slideshare.net/IntelCollab
To view the recording and download the PPT file,
please register for a trial membership at
http://IntelCollab.com.
Powered by
6. Case History
Anticipating and Outmaneuvering Competition
Reaction
Action
Pre market
testing
Hypothesize
positioning
Analysis
Data
gathering
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
7. Ongoing tracking
Data
gathering
Literature/published studies
Professional medical meetings
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
8. Efficacy and safety data
Analysis
Propose a professional label
Build hypothetical label
Identify anticipated product profile
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
9. Hypothesize
positioning
Identify most likely source of post
marketing competitive advantage
Build theoretical “USP”
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
10. Pre market
testing
Create competitor’s selling story
Convert story to sales aid
Test sales aid with customers
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
11. Apply learning to marketed brand
Action
Review original submission of
marketed brand for data on USP of
new brand
Determine if USP could be applied
to marketed brand
Apply learning and design sales
tools to adjust positioning
Roll out new USP
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
12. Reaction
Competitor’s response
Observed revised strategy of
marketed brand
Decided to submit new data to
alter launch strategy
Submitted new clinical trials and
supplemental application
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
13. Outcomes
Competitor’s product launch was
delayed 18 - 24 months
Marketed brand captured new
competitive position
Market share and brand protected
Market share and brand grew
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
14. Financial Benefits
Competitor’s
original planned
launch date
Analysis conducted of how this
competitor performed in other Rx
fields in first 18 - 24 months post
product launch
$
Delay of competitor and required
repositioning - worth $300-400
million in incremental global sales
Improved brand profitability due
to better new positioning
Marketed
brand
Competitor’s brand
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Time
Powered by
15. Thank you!
Now -- it’s time for some Q&A.
Cliff Kalb
Email: CKalb55205@aol.com
The Intelligence Collaborative is the online learning and networking
community powered by Aurora WDC, our clients, partners and other friends
and dedicated to exploring how to apply intelligence methods to solve realworld business problems.
Apply for a free 30-day trial membership at http://IntelCollab.com or learn
more about Aurora at http://AuroraWDC.com – see you next time!
The Intelligence Collaborative
http://IntelCollab.com #IntelCollab
Powered by
Notas do Editor
Ongoing tracking
- Phase I (dosing)
- Phase II (small scale trials - safety)
- Phase III (large scale trials - safety & efficacy)
Professional label content:
- Indications
- Efficacy
- Safety
- Tolerability
- Dosing frequency
- Dosing forms